PubMed · 1974 · 84 citations · 16 references
MedicineHematologyPathologyHematologic OncologyHematopathologyNeoplasiaPlatelet ActivationPlatelet DisordersPlatelet FunctionPlatelet PhysiologyThrombosisThrombotic DisordersPlatelet Metabolism
Abstract Autologous platelet survival studies using 51 Chromium ( 51 Cr) as a label are reported for five patients with nonhematologic malignancies and associated thrombocytosis. All patients had platelet counts greater than 550,000 per microliter. The in vivo platelet disappearance was linear with a life-span of 6.0 to 7.4 days. The platelet turnover rate (platelet count divided by life-span) was increased 2 to 4 times that measured in 10 normal subjects. Base on these data, the thrombocytosis seen in association with neoplasia can be explained by an increase in platelet production. The in vivo survival of these labeled platelets is mildly shortened.
16
Platelet Sequestration in Man. I. Methods*
Richard H. Aster, James H. Jandl · Journal of Clinical Investigation · 1964 · 819 citations · Full text
Laurence A. Harker, Clement A. Finch · Journal of Clinical Investigation · 1969 · 659 citations · Full text
Medicine, Hematology, Pathology +16
Platelet and Fibrinogen Consumption in Man
Laurence A. Harker, Sherrill J. Slichter · New England Journal of Medicine · 1972 · 494 citations
Medicine, Hematology, Hemostasis +9
Thrombocytosis Associated With Malignant Disease
Jack Levin · Archives of Internal Medicine · 1964 · 293 citations
Medicine, Hematology, Oncology +11